ECLIPSE DERMAFLEX MICROCANNULA Trademark

Trademark Overview


On Thursday, September 23, 2021, a trademark application was filed for ECLIPSE DERMAFLEX MICROCANNULA with the United States Patent and Trademark Office. The USPTO has given the ECLIPSE DERMAFLEX MICROCANNULA trademark a serial number of 97042200. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 12, 2024. This trademark is owned by Eclipse MedCorp, LLC. The ECLIPSE DERMAFLEX MICROCANNULA trademark is filed in the Medical Instrument Products category with the following description:

needles and cannulas for medical use
eclipse dermaflex microcannula

General Information


Serial Number97042200
Word MarkECLIPSE DERMAFLEX MICROCANNULA
Filing DateThursday, September 23, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Description of MarkThe mark consists of the words "ECLIPSE DERMAFLEX MICROCANNULA", in a stacked manner, with "DERMAFLEX", which contains a stylized cannula representing the "tail" portion of the letter "X", in the middle, "ECLIPSE" on top, and "MICROCANNULA" on the bottom.
NOT AVAILABLE"MICROCANNULA"
Goods and Servicesneedles and cannulas for medical use

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, October 25, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCROWN LABORATORIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJOHNSON CITY, TN 37604

Party NameCROWN LABORATORIES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressJOHNSON CITY, TN 37604

Party NameEclipse MedCorp, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressThe Colony, TX 75056

Trademark Events


Event DateEvent Description
Monday, September 27, 2021NEW APPLICATION ENTERED
Monday, October 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 26, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 15, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 24, 2022ASSIGNED TO EXAMINER
Saturday, June 25, 2022NON-FINAL ACTION WRITTEN
Saturday, June 25, 2022NON-FINAL ACTION E-MAILED
Saturday, June 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 8, 2023ASSIGNED TO LIE
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Wednesday, December 13, 2023SOU EXTENSION 1 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU EXTENSION 2 FILED
Wednesday, June 12, 2024SOU EXTENSION 2 GRANTED